Discovery and Characterization of a Peptide That Enhances Endosomal Escape of Delivered Proteins in Vitro and in Vivo
Authors:
- 30 October 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 137 (44) , 14084-14093
Abstract
The inefficient delivery of proteins into mammalian cells remains a major barrier to realizing the therapeutic potential of many proteins. We and others have previously shown that superpositively charged proteins are efficiently endocytosed and can bring associated proteins and nucleic acids into cells. The vast majority of cargo delivered in this manner, however, remains in endosomes and does not reach the cytosol. In this study we designed and implemented a screen to discover peptides that enhance the endosomal escape of proteins fused to superpositively charged GFP (+36 GFP). From a screen of peptides previously reported to disrupt microbial membranes without known mammalian cell toxicity, we discovered a 13-residue peptide, aurein 1.2, that substantially increases cytosolic protein delivery by up to ∼5-fold in a cytosolic fractionation assay in cultured cells. Four additional independent assays for nonendosomal protein delivery collectively suggest that aurein 1.2 enhances endosomal escape of associat...Keywords
Funding Information
- Howard Hughes Medical Institute
- National Institute on Deafness and Other Communication Disorders (R01 DC006908)
- Frederick and Ines Yeatts Hair Cell Regeneration Grant
- National Natural Science Foundation of China (81300824)
- National Institute of General Medical Sciences (R01 GM095501)
This publication has 47 references indexed in Scilit:
- Cas9 as a versatile tool for engineering biologyNature Methods, 2013
- Arginine Topology Controls Escape of Minimally Cationic Proteins from Early Endosomes to the CytoplasmChemistry & Biology, 2012
- Development trends for human monoclonal antibody therapeuticsNature Reviews Drug Discovery, 2010
- Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technologyCurrent Opinion in Biotechnology, 2009
- An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cellsProceedings of the National Academy of Sciences, 2009
- Comparison of Cellular Uptake Using 22 CPPs in 4 Different Cell LinesBioconjugate Chemistry, 2008
- Protein therapeutics: a summary and pharmacological classificationNature Reviews Drug Discovery, 2008
- Cytokines and interventional immunologyNature Reviews Immunology, 2007
- Enzyme Replacement Therapy in Fabry DiseaseJAMA, 2001
- PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.Diabetes, 1998